$0.65—Stale · unknown old
OTC • Last print unknown ago
$0.65—Stale · unknown old
Beijing Tong Ren Tang Chinese Medicine Company Limited specializes in traditional Chinese medicine with a strong emphasis on herbal products and proprietary formulations. The company operates primarily in China but has been expanding its international footprint, leveraging its brand heritage and extensive distribution network to capture market share in the growing global herbal medicine sector.
BJTRF generates revenue through the sale of traditional Chinese herbal medicines and health supplements, benefiting from strong brand recognition and a loyal customer base. The company maintains pricing power due to its established reputation and the perceived quality of its products, which are often viewed as premium offerings in the herbal market.
Regulatory changes affecting the herbal medicine market in China
Expansion of international sales channels, particularly in North America and Europe
Consumer trends towards natural and holistic health products
Changes in pricing strategy or product offerings
Regulatory changes that could restrict the sale or marketing of herbal products
Increasing competition from both domestic and international herbal medicine companies
Emerging brands that offer similar products at lower prices
Shifts in consumer preferences towards alternative health solutions
Low liquidity risk due to high current ratio of 19.65
Potential for margin compression if raw material costs increase significantly
moderate - The demand for herbal medicines can be sensitive to consumer spending patterns, which are influenced by broader economic conditions.
Low - Given the company's low debt levels, rising interest rates have minimal impact on financing costs; however, they may affect consumer spending indirectly.
minimal - The company operates with very low debt, reducing its exposure to credit market fluctuations.
value - The company's strong cash flow and low debt levels may attract value investors looking for stability.
low - The company has shown stable performance with minimal stock price fluctuations in recent periods.